Obesity and Metabolic Disorders

The metabolic syndrome is a condition categorised by a special constellation of reversible major risk factors for cardiovascular disease and type 2 diabetes. The basic, diagnostic, components are reduced HDL-cholesterol, raised triglycerides, blood pressure and fasting plasma glucose, all of which are related to weight gain, specifically intra-abdominal/ectopic fat accumulation and a large waist circumference. Metabolic syndrome is also promoted by a lack of internal adipose tissue, low skeletal muscle mass and anti-retroviral drugs. Reducing weight by 5–10%, by diet and exercise, with or without, anti-obesity drugs, significantly lowers all metabolic syndrome components, and risk of type 2 diabetes and cardiovascular disease. 

Obesity is a state in which a person has excess body fat. Obesity can rise a person's risk of diseases and health problems, including high blood pressure, diabetes and heart disease. It is a intricate problem and a major public health concern, both in the United States and worldwide. Obesity is most usually caused by a combination of excessive food intake, lack of physical activity, and genetic susceptibility.  A rare cases are caused primarily by genes, endocrine disorders, medications, or mental disorder. The view that obese people eat little so far gain weight due to a slow metabolism is not medically supported.

  • Hyperosmolar hyperglycemic nonketotic syndrome
  • Hyperglycemic Hyperosmolar Nonketotic coma
  • Diabetic coma
  • Dead in bed syndrome

Related Conference of Obesity and Metabolic Disorders

November 13-14, 2024

33rd International Diabetes and Healthcare Conference

Paris, France
November 18-19, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
November 18-19, 2024

3rd International Summit on Hormonal Disorders

Madrid, Spain
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 26-27, 2024

33rd International Conference on Clinical Diabetes, Diabetic Medication & Treatment

Paris, France
November 27-28, 2024

14th World Congress on Endocrinology and Diabetes

Paris, France
January 27-28, 2025

29th International Conference on Diabetes, Endocrinology and Healthcare

Dubai, UAE
February 24-25, 2025

34th European Diabetes Congress

London, UK
February 24-25, 2025

20th International Conference on Endocrinology and Metabolic Disorders

London, UK
March 10-11, 2025

18th European Diabetes and Endocrinology Congress

Rome, Italy
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

19th International Conference on Endocrinology, Diabetes and Metabolism

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
March 24-25, 2025

6th Global summit on Diabetes and Endocrinology

London, UK
April 07-08, 2025

36th International Congress on Prevention of Diabetes and Complications

Vancouver, Canada
April 10-11, 2025

31st International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

Dubai, UAE
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

27th World Congress on Diabetes and Endocrine Disorders

Dubai, UAE
May 05-06, 2025

24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

Rome, Italy
May 12-13, 2025

2nd International Congress on Endocrinology and Complications of Diabetes

Rome, Italy
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
June 24-25, 2025

23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare

Paris, France

Obesity and Metabolic Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in